Filter
105
Filtered Results: 105
Text search:
visceral
leishmaniasis
(VL)
Featured
Recommendations
4
New Publications
13
Language
Document type
No document type
29
Studies & Reports
27
Videos
11
Resource Platforms
9
Guidelines
8
Fact sheets
7
Strategic & Response Plan
5
Manuals
3
Infographics
3
Training Material
2
Online Courses
1
Countries / Regions
Global
42
Ethiopia
10
Latin America and the Carribbean
7
Nepal
6
Kenya
5
Bangladesh
5
India
5
Sudan
4
Middle East and North Africa
3
Brazil
3
South Sudan
3
Asia
2
South–East Asia Region
2
Western and Central Europe
2
Paraguay
2
Uganda
2
Greece
2
Somalia
2
North Macedonia
1
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Malawi
1
Morocco
1
Africa
1
Cambodia
1
Jordan
1
Saudi Arabia
1
North America
1
Tunisia
1
East and Southern Africa
1
Bolivia
1
Lebanon
1
Eastern Europe
1
Georgia
1
Iraq
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
21
Disease Prevention & Control
15
Statistics
9
Guidelines
7
Policies & Guidelines HIV & TB
5
Studies & Reports
5
Policies
4
Dermatology
3
Vector Control
2
Health System Strengthening
2
NTDs & Others
2
Parasitology
2
Pharmacy & Technologies
2
Paediatrics
1
Pediatrics
1
Chagas
1
Drugs & Medical Equipment
1
Capacity Building
1
Gynaecology & Obstetrics
1
Maternal Health
1
HIV & STI
1
Toolboxes
Information & Education Material (IEC)
22
Studies & Reports
19
Leishmaniasis
14
Statistics & Facts
7
Overview, Studies & Reports
5
NTDs General
4
Vector control
4
Community Health Workers CHW
3
Clinical Aspects & Diagnostics
3
Information & Education Material (IEC)
3
Opportunistic Infections
2
HIV
2
Others
2
Strategies & Roadmaps
2
Capacity Building & Resource platforms
2
Clinical Aspects, Treatment & Prevention
1
Clinical Aspects
1
Treatment Guidelines HIV
1
Climate & Health
1
Global Impact: Socio-economic, health services, TB & HIV
1
Pharmacy
1
Essential Medicines
1
General documents One Health
1
Infectious Diseases
1
Health Impact & Climate Change
1
Chagas
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Yaws & other Endemic Treponematoses
1
Antiretroviral Treatment ART
1
Reports & Studies Children HIV
1
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received...
Leishmaniasis is a climate-sensitive disease. Changes in
temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their
survival and population sizes. Increased temperatures shorten
vector development time, reduce Leishmania p...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
There is an urgent need to build Research and Development (R&D) capacity for leishmaniasis and other neglected tropical diseases (NTDs) in the Middle East and North Africa. The neglected tropical diseases are a group of 17 viral, bacterial, protozoan, and helminthic infections that often have high m...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
En la presente guía de capacitación se explica cómo reconocer los signos y los síntomas de las enfermedades tropicales desatendidas de la piel a partir de sus características visibles. También contiene información sobre cómo diagnosticar y tratar los problemas frecuentes de la piel que puede...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Situation Analaysis and Needs Assessment
La implementación de la presente Norma Nacional y Manual de Procedimientos Técnicos de la Leishmaniasis en el país, permitirá al personal de salud del sistema público y privado fortalecer sus capacidades técnicas y operativas a través de la estandarización y unificación de estrategias y acc...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The skin of a patient is the first and most visible structure of the body that any health-care worker encounters during the course of an examination. To the patient, it is also highly visible, and any disease that affects it is noticeable and will have an impact on personal and social well-being. Th...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
